Deutsche Bank Says They Continue To Like Allergan's Setup  In The Event Of Possible Pipeline News, But That The Co.'s Strong Q1 Results Were Overshadowed By The Ongoing Strategic Review Which Didn't Provide Specifics On Strategy Or Timing